GlaxoSmithKline

Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?

Should you sell GlaxoSmithKline plc (LON: GSK) and pile into this hot pharma stock? More »

Two 5% dividend yields you’d be crazy to pass up

If you're looking for income you can't go wrong with these two blue chips. More »

Does EKF Diagnostics Holding plc have more upside than GlaxoSmithKline plc after beating expectations?

Should you buy EKF Diagnostics Holding plc (LON: EKF) instead of GlaxoSmithKline plc (LON: GSK)? More »

Is today’s 10% riser Churchill China plc the perfect way to profit from Brexit?

Churchill China plc (LON:CHH) has surged higher after a strong 2016 so Roland Head asks: is this home-grown exporter a Brexit buy? More »

Are these the ultimate safety shares for a turbulent 2017?

Royston Wild looks at three Footsie stars with exceptional defensive qualities. More »

2 beginner stocks to kick-start a portfolio

Edward Sheldon looks at two stocks that he believes could be ideal choices for those looking to start an investment portfolio. More »

Why I’m bullish on GlaxoSmithKline plc for 2017

Why I believe GlaxoSmithKline plc (LON: GSK) is a top buy for 2017. More »

3 stocks you can buy with dividends yielding more than 5%

Royston Wild reveals a cluster of huge yielders with dynamite investment potential. More »

Here’s my top stock pick for 2017

Here's the undervalued dividend dog I'm betting on for 2017. More »

Better buy: GlaxoSmithKline plc vs Shire plc

Growth and income investors will both find something to cheer with GlaxoSmithKline plc (LON: GSK) and Shire plc (LON: SHP). More »

2 FTSE 100 stars you should consider buying before it’s too late

Royston Wild looks at two Footsie giants that could be about to explode. More »

Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?

Will AstraZeneca plc (LON: AZN) or GlaxoSmithKline plc (LON: GSK) soar over the medium-to-long term? More »

After recent declines, is this one of the FTSE 100’s best bargains?

Is this FTSE 100 (INDEXFTSE: UKX) income champion now the most attractive stock in the index? More »

2 stocks for your grandchildren to inherit

These shares may reward your grandchildren as much as you. More »

How GlaxoSmithKline plc’s first-mover advantage could power future profits

GlaxoSmithkline plc (LON: GSK) could be looking at its next blockbuster. More »

Is this an unmissable opportunity to buy these 2 FTSE 100 heroes?

These two FTSE 100 (INDEXFTSE: UKX) old favourites aren't exactly cheap, but they're cheaper than they were, says Harvey Jones. More »

Trump-induced share weakness is an opportunity with these 2 firms

Do this and Trump’s victory could help drive your stock market success. More »

Could GlaxoSmithKline plc learn something from Carr’s Group plc?

G A Chester sees value in Carr's Group plc (LON:CARR) and GlaxoSmithKline plc (LON:GSK). More »

These stocks are the FTSE’s true growth greats

Royston Wild looks at two FTSE 100 stocks with mindblowing growth potential. More »

Why did shares in Hikma Pharmaceuticals plc and GlaxoSmithKline plc crash last week?

Shares in GlaxoSmithKline plc (LON: GSK) and Hikma Pharmaceuticals plc (LON: HIK) are crashing but should you sell? More »